Shire PLC’s (SHP) “Overweight” Rating Reiterated at JPMorgan Chase & Co.
Shire PLC (LON:SHP)‘s stock had its “overweight” rating reiterated by equities researchers at JPMorgan Chase & Co. in a report released on Monday.
A number of other equities research analysts have also recently issued reports on SHP. BNP Paribas reaffirmed an “outperform” rating and issued a GBX 5,700 ($71.21) price objective on shares of Shire PLC in a research note on Monday, August 1st. Royal Bank Of Canada reaffirmed an “outperform” rating on shares of Shire PLC in a research note on Wednesday, August 3rd. Deutsche Bank AG reaffirmed a “buy” rating and issued a GBX 6,000 ($74.96) price objective on shares of Shire PLC in a research note on Wednesday, August 3rd. Citigroup Inc. reaffirmed a “buy” rating on shares of Shire PLC in a research note on Wednesday, August 3rd. Finally, Goldman Sachs Group Inc. reaffirmed a “conviction-buy” rating and issued a GBX 6,300 ($78.71) price objective on shares of Shire PLC in a research note on Wednesday, August 3rd. One investment analyst has rated the stock with a sell rating, seventeen have given a buy rating and one has given a strong buy rating to the stock. The stock currently has an average rating of “Buy” and a consensus price target of GBX 5,992.27 ($74.87).
Shire PLC (LON:SHP) opened at 4652.50 on Monday. The company has a 50-day moving average of GBX 4,877.05 and a 200-day moving average of GBX 4,732.37. Shire PLC has a 52 week low of GBX 2,707.19 and a 52 week high of GBX 5,377.00. The firm’s market capitalization is GBX 41.88 billion.
COPYRIGHT VIOLATION NOTICE: This piece was originally reported by The Cerbat Gem and is the propert of of The Cerbat Gem. If you are accessing this piece on another publication, it was illegally stolen and reposted in violation of United States and international trademark and copyright law. The correct version of this piece can be accessed at https://www.thecerbatgem.com/2016/11/28/shire-plcs-shp-overweight-rating-reiterated-at-jpmorgan-chase-co-2.html.
In other news, insider Dominic Blakemore acquired 133 shares of Shire PLC stock in a transaction on Friday, September 30th. The stock was acquired at an average cost of GBX 5,010 ($62.59) per share, for a total transaction of £6,663.30 ($8,324.96).
Shire PLC Company Profile
Shire plc is a biotech company. The Company, along with its subsidiaries, is engaged in developing and marketing medicines for patients with rare diseases and other select conditions. The Company operates in the segment of research, development, licensing, manufacturing, marketing, distribution and sale of specialist medicines.
Receive News & Stock Ratings for Shire PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Shire PLC and related stocks with our FREE daily email newsletter.